Pzena Investment Management LLC Boosts Stake in Koninklijke Philips (NYSE:PHG)

Pzena Investment Management LLC lifted its holdings in shares of Koninklijke Philips (NYSE:PHG) by 5.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 13,683 shares of the technology company’s stock after buying an additional 670 shares during the period. Pzena Investment Management LLC’s holdings in Koninklijke Philips were worth $346,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Bank of Montreal Can lifted its stake in Koninklijke Philips by 2,883.5% during the 3rd quarter. Bank of Montreal Can now owns 982,199 shares of the technology company’s stock valued at $32,157,000 after acquiring an additional 949,278 shares during the period. IHT Wealth Management LLC purchased a new position in shares of Koninklijke Philips during the third quarter valued at approximately $19,593,000. Raymond James Financial Inc. bought a new position in Koninklijke Philips during the fourth quarter valued at approximately $10,655,000. JPMorgan Chase & Co. boosted its holdings in Koninklijke Philips by 315.0% in the third quarter. JPMorgan Chase & Co. now owns 245,729 shares of the technology company’s stock worth $8,040,000 after purchasing an additional 186,520 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new stake in Koninklijke Philips in the 3rd quarter worth approximately $4,622,000. 13.67% of the stock is currently owned by institutional investors.

Koninklijke Philips Stock Down 0.0 %

NYSE PHG opened at $26.75 on Wednesday. The company has a quick ratio of 0.74, a current ratio of 1.23 and a debt-to-equity ratio of 0.59. Koninklijke Philips has a 52 week low of $19.10 and a 52 week high of $32.91. The company has a market capitalization of $25.15 billion, a P/E ratio of -31.85, a price-to-earnings-growth ratio of 0.82 and a beta of 0.78. The stock’s 50-day moving average price is $26.57 and its 200-day moving average price is $27.92.

Koninklijke Philips (NYSE:PHG) last announced its quarterly earnings data on Wednesday, February 19th. The technology company reported $0.54 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.55 by ($0.01). Koninklijke Philips had a positive return on equity of 10.85% and a negative net margin of 3.88%. The firm had revenue of $5.38 billion during the quarter, compared to analysts’ expectations of $5.10 billion. On average, equities research analysts predict that Koninklijke Philips will post 1.63 earnings per share for the current year.

Koninklijke Philips Cuts Dividend

The firm also recently disclosed an annual dividend, which will be paid on Friday, June 6th. Stockholders of record on Tuesday, May 13th will be given a $0.886 dividend. The ex-dividend date of this dividend is Tuesday, May 13th. This represents a dividend yield of 2.9%. Koninklijke Philips’s payout ratio is -89.29%.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on PHG shares. BNP Paribas raised Koninklijke Philips from a “neutral” rating to an “outperform” rating in a report on Tuesday, February 25th. StockNews.com upgraded Koninklijke Philips from a “hold” rating to a “buy” rating in a research report on Saturday. Finally, UBS Group raised Koninklijke Philips from a “neutral” rating to a “buy” rating in a research report on Thursday, February 20th. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, Koninklijke Philips presently has an average rating of “Moderate Buy”.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.